MedTrace Logo

Changes in Macular Thickness After Patterns Scan Laser

NCT00563628 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-05-30

No results posted yet for this study

Summary

Laser photocoagulation has become the treatment of choice in PDR. Laser photocoagulation has become the treatment of choice in TMD. The aim is to destroy a substantial portion of the peripheral retina in order to reduce the angiogenic stimulus (decrease the difference between oxygen demand and the administration). Their effectiveness is determined by the extent of destruction of the retina (2.4).

Conditions

  • Non Proliferative Diabetic Retinopathy
  • Proliferative Diabetic Retinopathy

Interventions

DEVICE

Panretinal photocoagulation with PASCAL system

Use the PASCAL laser system to deliver a retina photocoagulation

Sponsors & Collaborators

  • Asociación para Evitar la Ceguera en México

    lead OTHER

Principal Investigators

  • Raul Velez-Montoya, MD · Ascoiaciòn para Evitar la Ceguera en Mexico

  • Hugo Quiroz-Mercado, MD · Asociaciòn para Evitar la Ceguera

  • Virgilio Morales-Canton, MD · Asociaciòn para Evitar la Ceguera

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2007-10-31
Completion
2008-02-29

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00563628 on ClinicalTrials.gov